March 16, 2017 / 9:42 AM / 6 months ago

BRIEF-Oxford biomedica says FY EBITDA loss reduced to £7.1 mln

March 16 (Reuters) - Oxford Biomedica Plc

* Fy EBITDA loss reduced to £7.1 million

* Fy gross income increased by 64% to £30.8 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below